18 results
Oral Antihypertensive Medications - Selection by Comorbidities
Comorbidities: 
 • Stable Angina, HFpEF, HFrEF, AFib, TAA/Marfan, Aortic
Antihypertensive Medications ... Angina, HFpEF, ... HFrEF, AFib, TAA ... Antihypertensive #Medications ... #management
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
HF outcomes in HFrEF ... on GDMT, with or ... HF outcomes in HFrEF ... on GDMT, with or ... visualabstract #table
Diagnostic Algorithm for Treatment of Iron Deficiency in Patients With Heart Failure 

Consensus Recommendations 

#Iron #Deficiency
of Iron Deficiency ... #Deficiency #Management ... Diagnosis #Algorithm #HFrEF ... #HeartFailure #Indications ... #Treatment
Guideline-Directed Medical Therapy (GDMT) in HFrEF and CKD

 • Class I pillars of HFrEF GDMT across
) in HFrEF and CKD ... therapies" for HFrEF ... Chronotropes • Medications ... used in HFrEF: ... #CKD #HFrEF #management
Algorithm for screening/diagnosis and treatment/follow‐up of iron deficiency in patients with chronic heart failure. Hb, haemoglobin;
/follow‐up of iron ... , haemoglobin; HFrEF ... #Deficiency #Management ... #Diagnosis #HFrEF ... HeartFailure #Cardiology #Indications
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
Heart Failure (HFrEF ... ) Treatment - GDMT ... Ejection Fraction (HFrEF ... patients with HFrEF ... both of these medications
Treatment options for patients with Chronic Symptomatic Systolic Heart Failure

#sCHF #CongestiveHeartFailure #Systolic #HFrEF #Algorithm #Management #Cardiology
Treatment options ... CongestiveHeartFailure #Systolic #HFrEF ... #Algorithm #Management ... Cardiology #ivabradine #Medications
HFrEF: Guideline Directed Medical Therapy

"Must Be On"
 • ACEI, ARB, or ARNI AND select Beta Blockers
HFrEF: Guideline ... American patients #hfref ... #management #medications ... chf #cardiology #GDMT
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... Improved outcomes in CKD ... #diabetes #medications ... #management #endocrinology
Brief Overview of Treatment Agents for COVID-19 - Version 2.01 4/11/2020

#Drugs #Medications #Treatment #COVID19 #Pharmacology #Table
Agents for COVID ... 2020 #Drugs #Medications ... #Treatment #COVID19 ... #Pharmacology #Table ... #Management #MGH